Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Generex Biotechnology Corp. (GNBTQ) Message Board

What are Generex' priorities? What are we looking

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 36566
(Total Views: 214)
Posted On: 02/06/2020 7:38:40 AM
Posted By: Msowid
Re: hoops #11814
What are Generex' priorities? What are we looking forward to?

Dividends-GNBT and NGIO....happening, slowly, but happening

NGIO Spin-off/Listing on NASDAQ..have to pay the dividend, populate the board, submit an s1....go public when approved by finra....that's an easy one (pristine is how Joe described it)

AE 37 Trial Results....cancer research takes time, a looooong time...have to wait on this one.....

S-1 $40M....its a done deal...have to pay the dividend, to know how many shares outstanding, to price the s1...collect money at the ATM...

GNBT Uplisting....i hope they have put this on a back burner somewhere...this will not farewell for us....so please don't ask for it....

Excellagen sales and revenues....would 450,000 in Nov. sales impress you?....well we got that, b4 the indians started their orders....

Altucell Acquisition/By Extension Rebirth of Diabetes Franchise/Oralyn
dividend has to be paid, for finra to know shares outstanding, for finra to price s1, for generex to pay 2.5 million in cash to altucell for things to go....

MSO/Unsure of Its Current Stage of Completion....just waiting on funds from s1 to fire this baby back on....doctors are waiting in line...(its their investment)

Honestly, I have lost track of where we are in relation to other initiatives. Feel free to add them or insert your own priorities.

No one can say Generex is a one-trick biotech pony, but can all this still be accomplished? So much promise and so much concern. It definitely is not boring.

i'd rather be in this non-boring investment any day....much better than the 200 and 300 dollars am making daily on buying and selling stocks same hour....



(0)
(0)




Generex Biotechnology Corp. (GNBTQ) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us